The first patient injected for the PKD will be of interest but, IMO, won’t move the needle that much. The BIG mover, IMO, should be the renal marker and/or kidney volume measurements. IF they are good then there should be a “pile on” as instos try to get equity. They will have to buy off market from Mr Tribe or on-market from us. Either way it should result in a rerate. All I know is that the weasels won’t get mine cheaply!!
PYC Price at posting:
$1.20 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)